Cargando…
Cystic fluid neutrophil gelatinase-associated lipocalin (NGAL) concentration in differential diagnosis of pancreatic cystic lesions: a new factor enters the scene?
INTRODUCTION: Neutrophil gelatinase-associated lipocalin – 25 kDa peptide – is at present one of the most fascinating and unrecognised proteins implicated in the process of tumour development. Precise assessment of pancreatic cystic lesions is crucial for selecting available treatment options, such...
Autores principales: | Lipinski, Michal, Degowska, Malgorzata, Rydzewska, Grazyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040100/ https://www.ncbi.nlm.nih.gov/pubmed/30002772 http://dx.doi.org/10.5114/pg.2017.68805 |
Ejemplares similares
-
Pancreatic cystic lesions in diabetes mellitus patients
por: Rozek, Martyna, et al.
Publicado: (2020) -
Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer
por: Candido, Saverio, et al.
Publicado: (2014) -
The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL)
por: Romejko, Katarzyna, et al.
Publicado: (2023) -
Extracorporeal circulation causes release of neutrophil gelatinase-associated lipocalin (NGAL).
por: Jönsson, P, et al.
Publicado: (1999) -
3: A REVIEW OF NGAL BIOMARKER OR NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN
por: Bahramzadeh, Behzad
Publicado: (2017)